Aveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis

$12.360

+0.183 (+1.48%)At close

Loading chart…
High
12.380
Open
12.070
VWAP
12.27
Volume
2.03M
Mkt Cap
492.49M
Low
12.070
Amount
24.89M
EV/EBITDA, TTM
10.32

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.

AI analysis of Aveanna Healthcare Holdings Inc (AVAH)

Hold

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

Valuation Metrics

The current forward P/E ratio for Aveanna Healthcare Holdings Inc (AVAH) is 13.32, compared to its 5-year average forward P/E of 37.40.

Forward P/E

Fair
5Y Average P/E
37.40
Current P/E
13.32
Overvalued
140.10
Undervalued
-65.29

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
11.87
Current EV/EBITDA
10.32
Overvalued
13.41
Undervalued
10.32

Forward P/S

Strongly Overvalued
5Y Average P/S
0.41
Current P/S
0.92
Overvalued
0.65
Undervalued
0.17

Alphio AI Price Scenarios for AVAH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AVAH

$6.77

Scenario price

B

Base

Base · 50%AVAH

$6.66

Scenario price

B

Bear

Bear · 25%AVAH

$6.42

Scenario price

Whales holding AVAH

B

Braidwell LP

+ HoldingAVAH

+13.80%

3M Return

J

Jaunty Global Limited

+ HoldingAVAH

+0.65%

3M Return

Events Timeline

2026-08-20 (ET)

21:00:00

RBC Capital Prices Deal Within $11.65-$11.90 Range

20:00:00

US Treasury Yields Rise, Dow Drops Over 700 Points

16:30:00

Aveanna Healthcare Launches Secondary Offering of 15 Million Shares

2026-08-13 (ET)

07:30:00

Aveanna Reports Q2 Revenue of $670.48M, Exceeds Expectations

07:30:00

Aveanna Raises FY26 Adjusted EBITDA Outlook to Over $365M

News

AVAH FAQ — answered by Alphio AI

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading